Antidiabetic potential of the ethyl acetate extract of Physalis alkekengi and chemical constituents identified by HPLC-ESI-QTOF-MS

Journal of Ethnopharmacology

Volumn 225, Issue , 2018, Pages 202-210

  Zhang, Qiang ^a   Hu, Xiao Fang ^a   Xin, Man man ^a   Liu, Hong Bing ^b   Sun, Li Juan ^a   Morris Natschke, Susan L ^c   Chen, Yong ^a   Lee, Kuo Hsiung ^c,d  

^a HUBEI UNIVERSITY   (China)

^b State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics   (China)

^c UNC Hamner Institute for Drug Safety Sciences   (United States)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

2 NBDG uptake; Antidiabetic; Chemical constituents; Physalis alkekengi

Indexed keywords

4,7 DIDEHYDROPHYSALIN B; ACETIC ACID ETHYL ESTER; ANTIDIABETIC AGENT; APIGENIN; CAFFEOYLGLYCEROL; CHLOROGENIC ACID; CHOLESTEROL; CHRYSOERIOL; ESCULETIN; GLUCOSE; INSULIN; INSULIN SENSITIZING AGENT; LUTEOLIN; NEOCHLOROGENIC ACID; PHYSALIN A; PHYSALIN C; PHYSALIN L; PHYSALIN M; PHYSALIN N; PHYSALIN O; PHYSALIN Z; PHYSALIS ALKEKENGI PLANT EXTRACT; PLANT EXTRACT; PLASMA PROTEIN; PROTOCATECHUIC ACID; QUINIC ACID; ROSIGLITAZONE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITEXIN; ACETIC ACID; PHYTOCHEMICAL; SOLVENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CHEMICAL COMPOSITION; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; ELECTROSPRAY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HEP-G2 CELL LINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; HUMAN CELL; IN VITRO STUDY; INSULIN BLOOD LEVEL; INSULIN LEVEL; INSULIN SENSITIVITY; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PHYSALIS; PHYSALIS ALKEKENGI; QUADRUPOLE TIME OF FLIGHT MASS SPECTROMETRY; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TIME OF FLIGHT MASS SPECTROMETRY; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; CHEMISTRY; ELECTROSPRAY MASS SPECTROMETRY; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; METABOLISM; PHYTOTHERAPY; SPRAGUE DAWLEY RAT;

ACETATES; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE; GLUCOSE TOLERANCE TEST; HEP G2 CELLS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MALE; PHYSALIS; PHYTOCHEMICALS; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SOLVENTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 85049981536     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2018.07.007     Document Type: Article

References (37)

1. Bastos, G.N., Silveira, A.J., Salgado, C.G., Picanco-Diniz, D.L., do Nascimento, J.L., Physalis angulata extract exerts anti-inflammatory effects in rats by inhibiting different pathways. J. Ethnopharmacol. 118:2 (2008), 246–251.
2. Bigoniya, P., Nishad, R., Singh, C.S., Preventive effect of sesame seed cake on hyperglycemia and obesity against high fructose-diet induced Type 2 diabetes in rats. Food Chem. 133:4 (2012), 1355–1361.
3. Ceriello, A., Taboga, C., Tonutti, L., Quagliaro, L., Piconi, L., Bais, B., Ros, R.D., Motz, E., Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation 106:10 (2002), 1211–1218.
4. Committee, N.P., 2010. Pharmacopoeia of the People's Republic of China. Peking, Medical Science Press.
5. Dai, X., Ding, Y., Zhang, Z., Cai, X., Li, Y., Quercetin and quercitrin protect against cytokine‑induced injuries in RINm5F β-cells via the mitochondrial pathway and NF-κB signaling. Int. J. Mol. Med. 31:1 (2013), 265–271.
6. Del Rio, D., Rodriguez-Mateos, A., Spencer, J.P., Tognolini, M., Borges, G., Crozier, A., Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid. Redox Signal 18:14 (2013), 1818–1892.
7. El-Batran, S.A., Abdel-Salam, O.M., Nofal, S.M., Baiuomy, A.R., Effect of rosiglitazone and nateglinide on serum glucose and lipid profile alone or in combination with the biguanide metformin in diabetic rats. Pharmacol. Res. 53:1 (2006), 69–74.
8. Hanaa, F., Helmy, H., Abd El-Ghany, M., Antidiabetic and antioxidative activity of physalis powder or extract with chromium in rats. World J. Med. Sci. 7:1 (2012), 27–33.
9. Hu, X.F., Zhang, Q., Zhang, P.P., Sun, L.J., Liang, J.C., Morris-Natschke, S.L., Chen, Y., Lee, K.H., Evaluation of in vitro/in vivo anti-diabetic effects and identification of compounds from Physalis alkekengi. Fitoterapia, 2018, 10.1016/j.fitote.2018.02.015.
10. Huang, C., Xu, Q., Chen, C., Song, C., Xu, Y., Xiang, Y., Feng, F., Ouyang, H., Zhang, Y., Jiang, H., The rapid discovery and identification of physalins in the calyx of Physalis alkekengi L.var.franchetii (Mast.) Makino using ultra-high performance liquid chromatography-quadrupole time of flight tandem mass spectrometry together with a novel three-step data mining strategy. J. Chromatogr. A 1361 (2014), 139–152.
11. Hung, H.Y., Qian, K., Morris-Natschke, S.L., Hsu, C.S., Lee, K.H., Recent discovery of plant-derived anti-diabetic natural products. Nat. Prod. Rep. 29 (2012), 580–606.
12. Kamalakkannan, N., Prince, P.S., Antihyperglycaemic and antioxidant effect of rutin, a polyphenolic flavonoid, in streptozotocin-induced diabetic wistar rats. Basic Clinic Pharmacol. Toxicol. 98:1 (2006), 97–103.
13. Kim, M.J., Ryu, G.R., Chung, J.S., Sim, S.S., Min, D.S., Rhie, D.J., Yoon, S.H., Hahn, S.J., Kim, M.S., Jo, Y.H., Protective effects of epicatechin against the toxic effects of streptozotocin on rat pancreatic islets: in vivo and in vitro. Pancreas 26:3 (2003), 292–299.
14. Kim, W.H., Lee, J., Jung, D.W., Williams, D.R., Visualizing sweetness: increasingly diverse applications for fluorescent-tagged glucose bioprobes and their recent structural modifications. Sensors 12:4 (2012), 5005–5027.
15. Kota, N., Panpatil, V.V., Kaleb, R., Varanasi, B., Polasa, K., Dose-dependent effect in the inhibition of oxidative stress and anticlastogenic potential of ginger in STZ induced diabetic rats. Food Chem. 135:4 (2012), 2954–2959.
16. Kraegen, E.W., Clark, P.W., Jenkins, A.B., Daley, E.A., Chisholm, D.J., Storlien, L.H., Development of muscle insulin resistance after liver insulin resistance in high-fat–fed rats. Diabetes 40:11 (1991), 1397–1403.
17. Lan, Y.H., Chang, F.R., Pan, M.J., Wu, C.C., Wu, S.J., Chen, S.L., Wang, S.S., Wu, M.J., Wu, Y.C., New cytotoxic withanolides from Physalis peruviana. Food Chem. 116:2 (2009), 462–469.
18. Li, X., Zhao, J., Yang, M., Liu, Y., Li, Z., Li, R., Li, X., Li, N., Xu, Q., Khan, I.A., Yang, S., Physalins and withanolides from the fruits of Physalis alkekengi L. var. franchetii (Mast.) Makino and the inhibitory activities against human tumor cells. Phytochem. Lett. 10 (2014), 95–100.
19. Li, A.L., Chen, B.J., Li, G.H., Zhou, M.X., Li, Y.R., Ren, D.M., Lou, H.X., Wang, X.N., Shen, T., Physalis alkekengi L. var. franchetii (Mast.) Makino: an ethnomedical, phytochemical and pharmacological review. J. Ethnopharmacol. 210 (2018), 260–274.
20. Liebl, A., Mata, M., Eschwege, E., Board, O.D.E.A., Evaluation of risk factors for development of complications in Type II diabetes in Europe. Diabetologia 45:7 (2002), S23–S28.
21. Liu, J.F., Ma, Y., Wang, Y., Du, Z.Y., Shen, J.K., Peng, H.L., Reduction of lipid accumulation in HepG2 cells by luteolin is associated with activation of AMPK and mitigation of oxidative stress. Phytother. Res. 25:4 (2011), 588–596.
22. Louzao, M.C., Espiña, B., Vieytes, M.R., Vega, F.V., Rubiolo, J.A., Baba, O., Terashima, T., Botana, L.M., “Fluorescent glycogen” formation with sensibility for in vivo and in vitro detection. Glycoconj. J. 25:6 (2008), 503–510.
23. Magalhães, H.I., Veras, M.L., Torres, M.R., Alves, A.P., Pessoa, O.D., Silveira, E.R., Costa-Lotufo, L.V., de Moraes, M.O., Pessoa, C., In-vitro and in-vivo antitumour activity of physalins B and D from Physalis angulata. J. Pharmacy Pharmacol. 58:2 (2006), 235–241.
24. Olivares-Tenorio, M.L., Dekker, M., Verkerk, R., van Boekel, M.A.J.S., Health-promoting compounds in cape gooseberry (Physalis peruviana L.): review from a supply chain perspective. Trends Food Sci. Technol. 57 (2016), 83–92.
25. Ono, M., Fujimori, K., Antiadipogenic effect of dietary apigenin through activation of AMPK in 3T3-L1 cells. J. Agr. Food Chem. 59:24 (2011), 13346–13352.
26. Pang, A., Hu, Y., Zhou, P., Long, G., Tian, X., Men, L., Sheng, Y., Liu, Y., Cui, Y., Corin is down-regulated and exerts cardioprotective action via activating pro-atrial natriuretic peptide pathway in diabetic cardiomyopathy. Cardiovasc. Diabetol. 14 (2015), 134–146.
27. Raun, K., von Voss, P., Gotfredsen, C.F., Golozoubova, V., Rolin, B., Knudsen, L.B., Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body weight and food intake in obese candy-fed rats, whereas a dipeptidyl peptidase-IV inhibitor, vildagliptin, does not. Diabetes 56:1 (2007), 8–15.
28. Reed, M.J., Meszaros, K., Entes, L.J., Claypool, M.D., Pinkett, J.G., Gadbois, T.M., Reaven, G.M., A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 49:11 (2000), 1390–1394.
29. Srinivasan, K., Viswanad, B., Asrat, L., Kaul, C.L., Ramarao, P., Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol. Res. 52:4 (2005), 313–320.
30. Tahrani, A.A., Piya, M.K., Kennedy, A., Barnett, A.H., Glycaemic control in type 2 diabetes: targets and new therapies. Pharmacol. Ther. 125:2 (2010), 328–361.
31. Thackeray, J.T., deKemp, R.A., Beanlands, R.S., DaSilva, J.N., Early diabetes treatment does not prevent sympathetic dysinnervation in the streptozotocin diabetic rat heart. J. Nucl. Cardiol. 21:4 (2014), 829–841.
32. Wallace, T.M., Levy, J.C., Matthews, D.R., Use and abuse of HOMA modeling. Diabetes Care 27:6 (2004), 1487–1495.
33. Wojdylo, A., Oszmianski, J., Czemerys, R., Antioxidant activity and phenolic compounds in 32 selected herbs. Food Chem. 105:3 (2007), 940–949.
34. Wu, S.J., Tsai, J.Y., Chang, S.P., Lin, D.L., Wang, S.S., Huang, S.N., Ng, L.T., Supercritical carbon dioxide extract exhibits enhanced antioxidant and anti-inflammatory activities of Physalis peruviana. J. Ethnopharmacol. 108:3 (2006), 407–413.
35. Wu, T., Dorn, J.P., Donahue, R.P., Sempos, C.T., Trevisan, M., Associations of serum C-reactive protein with fasting insulin, glucose, and glycosylated hemoglobin: the Third National Health and Nutrition Examination Survey, 1988–1994. Am. J. Epidemiol. 155:1 (2002), 65–71.
36. Xu, Q.M., Liu, Y.L., Feng, Y.L., Li, X.R., Yang, S.L., C28 sterols with a cyclopentane ring at C-22 and 26 from cape gooseberry (berries of Physalis pubeacens L.). J. Asian Nat. Pro. Res. 12:9 (2010), 752–759.
37. Yu, G., Duan, Y.F., Fang, G.Z., Yan, Z., Wang, S., Study on biological activities of Physalis alkekengi var. francheti polysaccharide. J. Sci. Food Agr. 89:9 (2009), 1593–1598.